E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 3.522 EUR 3.04% Market Closed
Market Cap: 335.5m EUR
Have any thoughts about
Euroapi SAS?
Write Note

Intrinsic Value

The intrinsic value of one EAPI stock under the Base Case scenario is 4.441 EUR. Compared to the current market price of 3.522 EUR, Euroapi SAS is Undervalued by 21%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EAPI Intrinsic Value
4.441 EUR
Undervaluation 21%
Intrinsic Value
Price
E
Base Case Scenario

Valuation Backtest
Euroapi SAS

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for EAPI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about EAPI?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Euroapi SAS

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Euroapi SAS

Provide an overview of the primary business activities
of Euroapi SAS.

What unique competitive advantages
does Euroapi SAS hold over its rivals?

What risks and challenges
does Euroapi SAS face in the near future?

Has there been any significant insider trading activity
in Euroapi SAS recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Euroapi SAS.

Provide P/S
for Euroapi SAS.

Provide P/E
for Euroapi SAS.

Provide P/OCF
for Euroapi SAS.

Provide P/FCFE
for Euroapi SAS.

Provide P/B
for Euroapi SAS.

Provide EV/S
for Euroapi SAS.

Provide EV/GP
for Euroapi SAS.

Provide EV/EBITDA
for Euroapi SAS.

Provide EV/EBIT
for Euroapi SAS.

Provide EV/OCF
for Euroapi SAS.

Provide EV/FCFF
for Euroapi SAS.

Provide EV/IC
for Euroapi SAS.

Show me price targets
for Euroapi SAS made by professional analysts.

What are the Revenue projections
for Euroapi SAS?

How accurate were the past Revenue estimates
for Euroapi SAS?

What are the Net Income projections
for Euroapi SAS?

How accurate were the past Net Income estimates
for Euroapi SAS?

What are the EPS projections
for Euroapi SAS?

How accurate were the past EPS estimates
for Euroapi SAS?

What are the EBIT projections
for Euroapi SAS?

How accurate were the past EBIT estimates
for Euroapi SAS?

Compare the revenue forecasts
for Euroapi SAS with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Euroapi SAS and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Euroapi SAS against its competitors.

Analyze the profit margins
(gross, operating, and net) of Euroapi SAS compared to its peers.

Compare the P/E ratios
of Euroapi SAS against its peers.

Discuss the investment returns and shareholder value creation
comparing Euroapi SAS with its peers.

Analyze the financial leverage
of Euroapi SAS compared to its main competitors.

Show all profitability ratios
for Euroapi SAS.

Provide ROE
for Euroapi SAS.

Provide ROA
for Euroapi SAS.

Provide ROIC
for Euroapi SAS.

Provide ROCE
for Euroapi SAS.

Provide Gross Margin
for Euroapi SAS.

Provide Operating Margin
for Euroapi SAS.

Provide Net Margin
for Euroapi SAS.

Provide FCF Margin
for Euroapi SAS.

Show all solvency ratios
for Euroapi SAS.

Provide D/E Ratio
for Euroapi SAS.

Provide D/A Ratio
for Euroapi SAS.

Provide Interest Coverage Ratio
for Euroapi SAS.

Provide Altman Z-Score Ratio
for Euroapi SAS.

Provide Quick Ratio
for Euroapi SAS.

Provide Current Ratio
for Euroapi SAS.

Provide Cash Ratio
for Euroapi SAS.

What is the historical Revenue growth
over the last 5 years for Euroapi SAS?

What is the historical Net Income growth
over the last 5 years for Euroapi SAS?

What is the current Free Cash Flow
of Euroapi SAS?

Discuss the annual earnings per share (EPS)
trend over the past five years for Euroapi SAS.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Euroapi SAS

Balance Sheet Decomposition
Euroapi SAS

Current Assets 1.2B
Cash & Short-Term Investments 282.8m
Receivables 176.7m
Other Current Assets 696.3m
Non-Current Assets 640.1m
PP&E 504.3m
Intangibles 43.5m
Other Non-Current Assets 92.3m
Current Liabilities 735.9m
Accounts Payable 143.6m
Accrued Liabilities 60.8m
Short-Term Debt 452.6m
Other Current Liabilities 78.9m
Non-Current Liabilities 170.5m
Long-Term Debt 14.5m
Other Non-Current Liabilities 156m
Efficiency

Earnings Waterfall
Euroapi SAS

Revenue
971.3m EUR
Cost of Revenue
-805.8m EUR
Gross Profit
165.5m EUR
Operating Expenses
-161.2m EUR
Operating Income
4.3m EUR
Other Expenses
-291.6m EUR
Net Income
-287.3m EUR

Free Cash Flow Analysis
Euroapi SAS

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

EAPI Profitability Score
Profitability Due Diligence

Euroapi SAS's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative 1-Year Revenue Growth
Negative Revenue Growth Forecast
Low ROIC
29/100
Profitability
Score

Euroapi SAS's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

EAPI Solvency Score
Solvency Due Diligence

Euroapi SAS's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
43/100
Solvency
Score

Euroapi SAS's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EAPI Price Targets Summary
Euroapi SAS

Wall Street analysts forecast EAPI stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EAPI is 3.417 EUR with a low forecast of 3.03 EUR and a high forecast of 4.62 EUR.

Lowest
Price Target
3.03 EUR
14% Downside
Average
Price Target
3.417 EUR
3% Downside
Highest
Price Target
4.62 EUR
31% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for EAPI?

Click here to dive deeper.

Dividends

Euroapi SAS
does not pay dividends
Shareholder Yield

Current shareholder yield for EAPI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

EAPI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Euroapi SAS

Country

France

Industry

Pharmaceuticals

Market Cap

335.5m EUR

Dividend Yield

0%

Description

EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

Contact

ILE-DE-FRANCE
Paris
15 Rue Traversiere
+33189206200
www.euroapi.com

IPO

2022-05-06

Employees

3 342

Officers

CEO, Executive VP & Chief Transformation Officer
Mr. Ludwig De Mot
Chief Financial Officer
Mr. Olivier Falut
Chief Operating Officer
Mr. David Seignolle
Chief Scientific Officer
Mr. Kai Rossen
Head of Investor Relations
Sophie Palliez
Chief Legal, Compliance, & IP Officer
Ms. Marion Santin
Show More
Chief Human Resources Officer
Ute Herzog
Chief CDMO (Contract Development and Manufacturing Organization) Officer
Ms. Cecile Maupas
Chief Strategy and M&A Officer
Mr. Vincent Touraille
Chief Corporate Affairs Officer
Mr. Bruno Laforge
Show Less

See Also

Discover More
What is the Intrinsic Value of one EAPI stock?

The intrinsic value of one EAPI stock under the Base Case scenario is 4.441 EUR.

Is EAPI stock undervalued or overvalued?

Compared to the current market price of 3.522 EUR, Euroapi SAS is Undervalued by 21%.

Back to Top